GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Mabpharm Ltd (HKSE:02181) » Definitions » FCF Yield %

Mabpharm (HKSE:02181) FCF Yield % : 0.29 (As of Dec. 14, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Mabpharm FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Mabpharm's Trailing 12-Month Free Cash Flow is HK$3.7 Mil, and Market Cap is HK$1,299.1 Mil. Therefore, Mabpharm's FCF Yield % for today is 0.29%.

The historical rank and industry rank for Mabpharm's FCF Yield % or its related term are showing as below:

HKSE:02181' s FCF Yield % Range Over the Past 10 Years
Min: -29.96   Med: -10.06   Max: 3.51
Current: 0.29


During the past 7 years, the highest FCF Yield % of Mabpharm was 3.51%. The lowest was -29.96%. And the median was -10.06%.

HKSE:02181's FCF Yield % is ranked better than
86% of 1507 companies
in the Biotechnology industry
Industry Median: -12.96 vs HKSE:02181: 0.29

Mabpharm's FCF Margin % for the quarter that ended in Jun. 2024 was -70.80%.


Mabpharm FCF Yield % Historical Data

The historical data trend for Mabpharm's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mabpharm FCF Yield % Chart

Mabpharm Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
FCF Yield %
Get a 7-Day Free Trial -5.87 -9.43 -10.34 -11.33 2.21

Mabpharm Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -10.17 -9.08 -4.36 9.11 -10.15

Competitive Comparison of Mabpharm's FCF Yield %

For the Biotechnology subindustry, Mabpharm's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mabpharm's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Mabpharm's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Mabpharm's FCF Yield % falls into.



Mabpharm FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Mabpharm's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=41.946 / 1897.0768
=2.21%

Mabpharm's annualized FCF Yield % for the quarter that ended in Jun. 2024 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-82.684 * 2 / 1629.0116
=-10.15%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mabpharm FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Mabpharm FCF Yield % Related Terms

Thank you for viewing the detailed overview of Mabpharm's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Mabpharm Business Description

Traded in Other Exchanges
N/A
Address
Lujia Road East, Koutai Road West, Block G79, China Medical City, Taizhou, CHN, 225300
Mabpharm Ltd is a biopharmaceutical company. The company is engaged in the research, development, and production of new drugs and biosimilars for cancers and autoimmune diseases. Its core products include CMAB008 (infliximab), CMAB007 (omalizumab), and CMAB009 (cetuximab).
Executives
Guo Jianjun 2307 Founder of a discretionary trust who can infl
Asia Mabtech Limited
Asia Pacific Immunotech Venture Limited
Guo Family (ptc) Limited
Fortune-healthy Investment Limited
Link Best Capital Limited
Cdh Fund V, L.p.
Cdh Mabtech Limited
Cdh V Holdings Company Limited
China Diamond Holdings Company Limited
China Diamond Holdings V Limited

Mabpharm Headlines

No Headlines